PAA 2.94% 17.5¢ pharmaust limited

Amylyx class action Relyvrio, page-3

  1. 475 Posts.
    lightbulb Created with Sketch. 753
    Hi All,

    Brilliant post KPAX c/o Quiltman.

    When shareholders, current and prospective, grasp the magnitude of the latest results of the MEND trial, the selling will stop.

    That being said, as our new CEO stated, "BLOCKBUSTER", there is a reason for that.

    Put simply, MPL is a blockbuster drug!!

    Hold onto your shares, as when ODD, is approved, BP's, will want to partner up.

    That's when things will get interesting!

    FOMO, is just about to set in, again!!

    As Always

    Best

    Mickey Mouse
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.005(2.94%)
Mkt cap ! $69.28M
Open High Low Value Volume
17.5¢ 18.5¢ 17.5¢ $427.5K 2.394M

Buyers (Bids)

No. Vol. Price($)
6 103443 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 130237 3
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.005 ( 3.51 %)
Open High Low Volume
17.5¢ 18.5¢ 17.5¢ 1774886
Last updated 15.59pm 13/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.